Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3706-5 ◽

2018 ◽

Vol 83 (1) ◽

pp. 97-105 ◽

Cited By ~ 2

Author(s):

Kristina Lindemann ◽

◽

Philip J. Beale ◽

Emma Rossi ◽

Jeff C. Goh ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Study ◽

Platinum Sensitive

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71047-9 ◽

2007 ◽

Vol 5 (4) ◽

pp. 272-273

Author(s):

C. Morizane ◽

T. Okusaka ◽

J. Furuse ◽

H. Ishii ◽

H. Ueno ◽

...

Keyword(s):

Pancreatic Cancer ◽

Combination Therapy ◽

Phase I ◽

Cancer Patients ◽

Phase I Study ◽

Fixed Dose ◽

Fixed Dose Rate ◽

Fixed Dose Rate Infusion ◽

Gemcitabine Refractory ◽

Rate Infusion

Results of a phase I study of fixed dose rate gemcitabine /irinotecan (FIGI)

10.1200/jco.2004.22.14_suppl.2112 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2112-2112

Author(s):

T. Ryan ◽

H. Hochster ◽

J. Escalon ◽

F. M. Muggia

Keyword(s):

Phase I ◽

Dose Rate ◽

Phase I Study ◽

Fixed Dose ◽

Phase I study of fixed-dose rate (FDR) gemcitabine with capecitabine in advanced solid malignancies

10.1200/jco.2008.26.15_suppl.13509 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 13509-13509

Author(s):

S. Attia ◽

J. Eickhoff ◽

K. D. Holen ◽

H. Bailey ◽

D. Alberti ◽

...

Keyword(s):

Phase I ◽

Dose Rate ◽

Phase I Study ◽

Fixed Dose ◽

Solid Malignancies ◽

A phase I study of the vascular-disrupting agent BNC105P in combination with gemcitabine-carboplatin in platinum-sensitive ovarian cancer patients in first or second relapse.

10.1200/jco.2014.32.15_suppl.5524 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5524-5524 ◽

Cited By ~ 1

Author(s):

Danny Rischin ◽

Philip James Beale ◽

Emma Caroline Rossi ◽

Jeffrey C. Goh ◽

Michelle Margaret Vaughan ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Study ◽

Vascular Disrupting Agent ◽

Platinum Sensitive ◽

Vascular Disrupting

321: A New Concept of Continuous Gemcitabine Infusion: Fixed-Dose-Rate Gemcitabine Plus Platinum in Metastatic Transitional Cell Cancer-Preliminary Results of a Phase I Study

The Journal of Urology ◽

10.1016/s0022-5347(18)37583-9 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 84-84

Author(s):

Christian M. Lippert ◽

Thomas Meisel ◽

Martin Soder ◽

Hans Matthias Weber ◽

Kai D. Braun ◽

...

Keyword(s):

Phase I ◽

Dose Rate ◽

Phase I Study ◽

Cell Cancer ◽

Transitional Cell ◽

Fixed Dose ◽

Preliminary Results ◽

Fixed Dose Rate ◽

Transitional Cell Cancer

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

Investigational New Drugs ◽

10.1007/s10637-012-9863-1 ◽

2012 ◽

Vol 31 (3) ◽

pp. 685-695 ◽

Cited By ~ 16

Author(s):

Amir Mortazavi ◽

Yonghua Ling ◽

Ludmila Katherine Martin ◽

Lai Wei ◽

Mitch A. Phelps ◽

...

Keyword(s):

Phase I ◽

Dose Rate ◽

Solid Tumors ◽

Phase I Study ◽

Fixed Dose ◽

Advanced Solid Tumors ◽

Prolonged Infusion ◽

A new concept of continuous gemcitabine infusion: Fixed-dose-rate gemcitabine plus Platinum in metastatic transitional cancer –preliminary results of a phase I study

10.1200/jco.2004.22.14_suppl.4641 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4641-4641

Author(s):

C. M. Lippert ◽

T. Meisel ◽

E. Becht ◽

G. Staehler

Keyword(s):

Phase I ◽

Dose Rate ◽

Phase I Study ◽

Fixed Dose ◽

Preliminary Results ◽

A phase I study of pegylated liposomal doxorubicin + gemcitabine in a fixed dose-rate infusion for the treatment of patients with recurrent ovarian cancer

10.1200/jco.2008.26.15_suppl.5579 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5579-5579

Author(s):

G. Crespo ◽

M. Sierra ◽

R. Losa ◽

N. Villanueva ◽

J. Fra ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Fixed Dose ◽

Fixed Dose Rate ◽

Fixed Dose Rate Infusion ◽

Rate Infusion

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1786-6 ◽

2011 ◽

Vol 69 (4) ◽

pp. 957-964 ◽

Cited By ~ 6

Author(s):

Chigusa Morizane ◽

Takuji Okusaka ◽

Hideki Ueno ◽

Shunsuke Kondo ◽

Masafumi Ikeda ◽

...

Keyword(s):

Pancreatic Cancer ◽

Combination Therapy ◽

Phase I ◽

Dose Rate ◽

Cancer Patients ◽

Fixed Dose ◽

Fixed Dose Rate ◽

Fixed Dose Rate Infusion ◽

Gemcitabine Refractory ◽

Rate Infusion